药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Glucosamine
Melengestrol
The risk or severity of adverse effects can be increased when Ponatinib is combined with Melengestrol.
Glucosamine
Tepoxalin
The risk or severity of adverse effects can be increased when Ponatinib is combined with Tepoxalin.
Glucosamine
Fluprednisolone
The risk or severity of adverse effects can be increased when Ponatinib is combined with Fluprednisolone.
Glucosamine
Antilymphocyte immunoglobulin (horse)
The risk or severity of adverse effects can be increased when Ponatinib is combined with Antilymphocyte immunoglobulin (horse).
Glucosamine
Peginterferon beta-1a
The risk or severity of adverse effects can be increased when Ponatinib is combined with Peginterferon beta-1a.
Glucosamine
Tixocortol
The risk or severity of adverse effects can be increased when Ponatinib is combined with Tixocortol.
Glucosamine
Vilanterol
The risk or severity of adverse effects can be increased when Ponatinib is combined with Vilanterol.
Glucosamine
Dinutuximab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Dinutuximab.
Glucosamine
Blinatumomab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Blinatumomab.
Glucosamine
Vedolizumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Vedolizumab.
Glucosamine
Obinutuzumab
The risk or severity of adverse effects can be increased when Ponatinib is combined with Obinutuzumab.
Glucosamine
Dimethyl fumarate
The risk or severity of adverse effects can be increased when Ponatinib is combined with Dimethyl fumarate.
Glucosamine
Belimumab
The risk or severity of adverse effects can be increased when Belimumab is combined with Ponatinib.
Glucosamine
Ruxolitinib
The risk or severity of adverse effects can be increased when Ruxolitinib is combined with Ponatinib.
Glucosamine
Eribulin
The risk or severity of adverse effects can be increased when Eribulin is combined with Ponatinib.
Glucosamine
Wortmannin
The risk or severity of adverse effects can be increased when Wortmannin is combined with Ponatinib.
Glucosamine
Belatacept
The risk or severity of adverse effects can be increased when Belatacept is combined with Ponatinib.
Glucosamine
Abetimus
The risk or severity of adverse effects can be increased when Abetimus is combined with Ponatinib.
Glucosamine
Mepolizumab
The risk or severity of adverse effects can be increased when Mepolizumab is combined with Ponatinib.
Glucosamine
Human interferon omega-1
The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Ponatinib.